A Retrospective Chart Review of BOTOX and Xeomin for the Management of Cervical Dystonia and Blepharospasm
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2016
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Torticollis
- Focus Therapeutic Use
- Sponsors Allergan
- 07 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrial.gov record.
- 27 Oct 2015 Planned number of patients changed from 230 to 40 as reported by ClinicalTrial.gov record.
- 27 Oct 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015 as reported by ClinicalTrial.gov record.